Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor models
about
CNS Anticancer Drug Discovery and Development Conference White Paper.Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas.Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats.Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.TGF-β signaling in liver and gastrointestinal cancers
P2860
Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor models
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preclinical pharmacological ev ...... N123300, in brain tumor models
@ast
Preclinical pharmacological ev ...... N123300, in brain tumor models
@en
Preclinical pharmacological ev ...... 123300, in brain tumor models.
@nl
type
label
Preclinical pharmacological ev ...... N123300, in brain tumor models
@ast
Preclinical pharmacological ev ...... N123300, in brain tumor models
@en
Preclinical pharmacological ev ...... 123300, in brain tumor models.
@nl
prefLabel
Preclinical pharmacological ev ...... N123300, in brain tumor models
@ast
Preclinical pharmacological ev ...... N123300, in brain tumor models
@en
Preclinical pharmacological ev ...... 123300, in brain tumor models.
@nl
P2093
P2860
P1476
Preclinical pharmacological ev ...... N123300, in brain tumor models
@en
P2093
E Premkumar Reddy
James M Gallo
M V Ramana Reddy
Qingyu Zhou
Rana Elkholi
Xiaoping Zhang
P2860
P304
P356
10.1158/1535-7163.MCT-13-0847
P577
2014-02-25T00:00:00Z